| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.0041 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |